Evaluation of the fully automated LIAISON®XL chemiluminescence analyzer for QuantiFERON®-CMV testing in transplant recipients. Évaluation de l'analyseur par chimiluminescence LIAISON®XL entièrement automatisé pour le test QuantiFERON®-CMV chez les receveurs de greffe

Archive ouverte

Mafi, Sarah | Alain, Sophie | Hantz, Sébastien

Edité par CCSD ; Elsevier -

International audience. Background: Monitoring CMV-specific cell-mediated immunity by the QuantiFERON®-CMV (QF-CMV) may beuseful in predicting the risk of CMV infection in transplant recipients (TR).Objectives: As the QuantiFERON-Tuberculosis (QFT®-Plus) became available on the fully automated LIAISON®XLchemiluminescence (CLIA) analyzer, we evaluated the performance of the QF-CMV on the LIAISON®XL analyzerusing the QuantiFERON®-TB Gold Plus reagent.Study design: Between 2018 and 2022, 81 samples from TR were collected at the Department of Virology ofLimoges Hospital, France. Whole blood was collected into each of the three QF-CMV collection tubes: a CMVantigentube (QF-Ag), a mitogen tube (QF-Mg) (positive control), and a nil tube (negative control). The QFCMVwas performed on the LIAISON®XL analyzer, and results were compared with those obtained by conventionalmicroplate ELISA.Results: Intra- and inter-assay coefficients of variation were inferior to 20%. No inter-sample contamination wasfound (p=0.366). The level of concordance between CLIA and the commonly used ELISA method was 88.9%.Positive and negative percent agreements were 92.3% and 85.7%, respectively, with a very good agreementbetween assays (κ=0.818). Most discordances were due to indeterminate- or negative-ELISA/positive-CLIA results(most of ELISA results were borderline). Linear regression analyses demonstrated a strong correlation betweenboth assays (QF-Ag Pearson’s r=0.978, QF-Mg Pearson’s r=0.963). No significant difference was observedin median QF-CMV values between both assays (QF-Ag p=0.776; QF-Mg p=0.853; Mann-Whitney U test). TheBland-Altman plots showed a minor difference in IFN-γ release (QF-Ag -0.069 IU/ml, 95% limits of agreement(LoA): -1.589; 1.451; QF-Mg 0.190 IU/ml, 95% LoA: -2.070; 2.450).Conclusion: Automated QF-CMV with CLIA is comparable to QF-CMV performed by ELISA with a presumablyhigher sensitivity for IFN-γ detection that may result in the conversion of samples close to the ELISA cut-off intopositive results. Moreover, the use of a random-access analyzer allows to optimize the follow-up of TR.

Consulter en ligne

Suggestions

Du même auteur

Torque teno virus viremia and QuantiFERON®-CMV assay in prediction of cytomegalovirus reactivation in R+ kidney transplant recipients

Archive ouverte | Mafi, Sarah | CCSD

International audience. Conclusion: The combination of TTV load and QF-Ag or TTV load and QF-Mg could be useful in stratifying the risk of CMV reactivation in R+ KTR during the first post-transplant year and thereby...

Challenges and advances in the management of HCMV infections. Enjeux et avancées de la prise en charge des infections à CMVH

Archive ouverte | Gourin, Claire | CCSD

International audience. Human cytomegalovirus (HCMV) is one of the most important causes of complications in immunocompromised patients and congenital infections. HCMV could also represent an interesting target for ...

Performance of the SureScreen Diagnostics COVID-19 antibody rapid test in comparison with three automated immunoassays. Performance du test rapide SureScreen Diagnostics pour l'anticorps COVID-19 par rapport à trois immunodosages automatisés

Archive ouverte | Mafi, Sarah | CCSD

International audience. Lateral flow immunoassays (LFIA) for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies are used for population surveillance and potentially individual risk ...

Chargement des enrichissements...